Urinary Tract Infection, Males: Multimedia

References

1. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968;5:492-518. [Medline].

2. McNaughton Collins M, Fowler FJ Jr, et al. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test?. Urology. Mar 2000;55(3):403-7. [Medline].

3. Nickel JC. The pre and post massage test (PPMT): a simple screen for prostatitis. Tech Urol. 1997;3:38-43. [Medline].

4. [Guideline] CDC. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. Apr 13 2007;56(14):332-6. [Medline]. [Full Text].

5. Saint S, Elmore JG, Sullivan SD, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med. Sep 1998;105(3):236-41. [Medline].

6. Afgan F, Mumtaz S, Ather MH. Preoperative diagnosis of xanthogranulomatous pyelonephritis. Urol J. Summer 2007;4(3):169-73. [Medline].

7. Alves LS, Assis BP, Rezende MM. Schistosomal epididymitis. Int Braz J Urol. Sep-Oct 2004;30(5):413-5. [Medline].

8. Anderson RU. Management of lower urinary tract infections and cystitis. Urol Clin North Am. Nov 1999;26(4):729-35, viii. [Medline].

9. Ateya A, Fayez A, Hani R, et al. Evaluation of prostatic massage in treatment of chronic prostatitis. Urology. Apr 2006;67(4):674-8. [Medline].

10. Barry MJ, Fowler FJ Jr., O'Leary MP. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549-57, 1564. [Medline].

11. Behr MA, Drummond R, Libman MD. Fever Duration in Hospitalized Acute Pyelonephritis Patients. Am J Med. 1996;101:277-80. [Medline].

12. Bergeron MG. Treatment of Pyelonephritis in Adults. Med Clin North Amer. 1995;79:619-49. [Medline].

13. Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis. Feb 1 2006;193(3):336-45. [Medline].

14. Burgher SW. Acute Scrotal Pain. Emerg Med Clin North Amer. 1998;16:781-809. [Medline].

15. [Guideline] CDC, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. Aug 4 2006;55(RR-11):1-94. [Medline]. [Full Text].

16. Chiang IN, Chang SJ, Pu YS, et al. Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in taiwan. J Formos Med Assoc. Nov 2007;106(11):929-34. [Medline].

17. Chua A, Klein NC, Cunha BA. The Diagnostic Significance of Urinary Nitrate in Hospitalized Patients with Catheter Associated Bacteruria. Infectious Disease Practice. 1999;23:9-11.

18. Collins MM, Stafford RS, O'Leary MP, et al. How common is prostatitis? A national survey of physician visits. J Urol. Apr 1998;159(4):1224-8. [Medline].

19. Crawford ED, Haynes AL Jr, Story MW, et al. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol. Mar 1982;127(3):449-51. [Medline].

20. Cunha BA. Antibiotic Essentials. 7^th ed. Royal Oak, Mich: Physicians Press; 2008.

21. Cunha BA. Clinical Concepts in the Treatment of Urinary Tract Infections. Antibiotics for Clinicians. 1999;3:88-93.

22. Cunha BA. Concentration Dependent Susceptibility of Urinary Tract Isolates. Antibiotics for Clinicians. 1999;3:57-8.

23. Cunha BA. Urosepsis in the Critical care Unit. In: Cunha BA. Infectious Disease in Critical Care Medicine. 2nd Ed. New York, NY: Informa Healthcare; 2007:pp. 527-534.

24. Cunha BA. Nitrofurantoin: A Review. Advances in Therapy. 1989;6:213-36.

25. Cunha BA. Urosepsis. Journal of Critical Illness. 1997;12:616-25.

26. Cunha BA, Comer JB. Pharmacokinetic considerations in the treatment of urinary tract infections. Conn Med. Jun 1979;43(6):347-53. [Medline].

27. Daniels NA, Ewing SK, Zmuda JM, et al. Correlates and prevalence of prostatitis in a large community-based cohort of older men. Urology. Nov 2005;66(5):964-70. [Medline].

28. Donzella JG, Merrick GS, Lindert DJ, et al. Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland. Urology. Feb 2004;63(2):306-8. [Medline].

29. Díaz M, Vidal A, Iglesias E, et al. [Epididymo-orchitis as the first manifestation of tuberculous reactivation]. An Med Interna. May 2004;21(5):254-5. [Medline].

30. Egan KJ, Krieger JL. Chronic abacterial prostatitis - a urological chronic pain syndrome?. Pain. 1997;69:213-8. [Medline].

31. Ehrhardt S, Lippert U, Burchard GD, et al. Orchitis as an unusual manifestation of human African trypanosomiasis. J Infect. Jan 2006;52(1):e31-3. [Medline].

32. Falkensammer C, Gozzi C, Hager M, et al. Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma. Urology. Jan 2005;65(1):175. [Medline].

33. Guercio S, Terrone C, Tarabuzzi R, et al. PSA decrease after levofloxacin therapy in patients with histological prostatitis. Arch Ital Urol Androl. Dec 2004;76(4):154-8. [Medline].

34. Hoffelt SC, Wallner K, Merrick G. Epididymitis after prostate brachytherapy. Urology. Feb 2004;63(2):293-6. [Medline].

35. Hua VN, Schaeffer AJ. Acute and chronic prostatitis. Med Clin North Am. Mar 2004;88(2):483-94. [Medline].

36. Hummers-Pradier E, Ohse AM, Koch M, et al. Urinary tract infection in men. Int J Clin Pharmacol Ther. Jul 2004;42(7):360-6. [Medline].

37. Jacobs L, Dorsainvil P, Cunha BA. Urinary Tract Infections in Patients with IgA and IgG Multiple Myeloma. Infectious Disease Practice. 2006;30:483-6.

38. Kaplan SA, Te AE, Jacobs BZ. Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck. J Urol. Dec 1994;152(6 Pt 1):2063-5. [Medline].

39. Kravchick S, Cytron S, Agulansky L, et al. Acute prostatitis in middle-aged men: a prospective study. BJU Int. Jan 2004;93(1):93-6. [Medline].

40. Krieger JN. The problem with prostatitis. What do we know? What do we need to know?. J Urol. Aug 2004;172(2):432-3. [Medline].

41. Lipsky BA. Prostatitis and urinary tract infection in men: what's new; what's true?. Am J Med. Mar 1999;106(3):327-34. [Medline].

42. Lipsky BA. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med. Jan 15 1989;110(2):138-50. [Medline].

43. Luzzi G. Chronic prostatitis. N Engl J Med. Jan 25 2007;356(4):423-4; author reply 424. [Medline].

44. Mohan H, Bal A, Punia RP, et al. Granulomatous prostatitis--an infrequent diagnosis. Int J Urol. May 2005;12(5):474-8. [Medline].

45. Moon TD. Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis. Urology. Oct 1997;50(4):543-7. [Medline].

46. Muttarak M, Peh WC. Case 91: Tuberculous Epididymo-orchitis. Radiology. Feb 2006;238(2):748-51. [Medline].

47. Mändar R, Raukas E, Türk S, et al. Mycoplasmas in semen of chronic prostatitis patients. Scand J Urol Nephrol. 2005;39(6):479-82. [Medline].

48. Naber KG. Levofloxacin in the treatment of urinary tract infections and prostatitis. J Chemother. Apr 2004;16 Suppl 2:18-21. [Medline].

49. National Institute of Health Summary Statement. Workshop on chronic prostatitis. National Institute of Health, Bethesda MD. December 1995;[Full Text].

50. Nickel JC. Effective office management of chronic prostatitis. Urol Clin North Am. 1998;25:677-84. [Medline].

51. Nickel JC. Prostatitis: evolving management strategies. Urol Clin North Am. 1999;26:737-51. [Medline].

52. Nickel JC, Alexander R, Anderson R. Prostatitis unplugged? Prostatic massage revisited. Tech Urol. 1999;5:1-7. [Medline].

53. Nickel JC, Nigro M, Valiquette L. Diagnosis and treatment of prostatitis in Canada. Urology. 1998;52:797-802. [Medline].

54. Nickel JC, Teichman JM, Gregoire M, et al. Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study. Urology. Nov 2005;66(5):935-40. [Medline].

55. O'Leary JJ, Domenico P, Cunha BA. Importance of Urinalysis in Infectious Disease. Hospital Physician. 1991;27:25-30.

56. Oben FT, Wright RD, Ahaghotu CA. Tuberculous epididymitis with extensive retroperitoneal and mediastinal involvement. Urology. Jul 2004;64(1):156-8. [Medline].

57. Orenstein R, Wong ES. Urinary Tract Infections in Adults. Am Fam Physician. 1999;59:1225-34, 1237. [Medline].

58. Pewitt EB, Schaeffer AJ. Urinary Tract Infection in Urology, Including Acute and Chronic Prostatitis. Infect Dis Clin North Amer. 1997;11:623-46. [Medline].

59. Platt R, Polk BF, Murdock B, et al. Risk factors for nosocomial urinary tract infection. Am J Epidemiol. Dec 1986;124(6):977-85. [Medline].

60. Pontari MA, Joyce GF, Wise M, et al. Prostatitis. J Urol. Jun 2007;177(6):2050-7. [Medline].

61. Pronk MJ, Pelger RC, Baranski AG, et al. Cure of chronic prostatitis presumably due to Enterococcus spp and gram-negative bacteria. Eur J Clin Microbiol Infect Dis. Apr 2006;25(4):270-1. [Medline].

62. Quintiliani R, Klimek J, Cunha BA, et al. Bacteraemia after manipulation of the urinary tract. The importance of pre-existing urinary tract disease and compromised host defences. Postgrad Med J. Oct 1978;54(636):668-71. [Medline].

63. Roberts RO, Lieber MM, Rhodes T. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of urinary symptoms and health status among men. Urology. 1998;51:578-84. [Medline].

64. Saint S, Lipsky BA. Preventing Catheter-Related Bacteriuria: Should we? Can we? How?. Arch Intern Med. 1999;159:800-8. [Medline].

65. Schaeffer AJ, Wu SC, Tennenberg AM, et al. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. J Urol. Jul 2005;174(1):161-4. [Medline].

66. Shoskes DA, Lee CT, Murphy D, et al. Incidence and significance of prostatic stones in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. Aug 2007;70(2):235-8. [Medline].

67. Sindhwani P, Wilson CM. Prostatitis and serum prostate-specific antigen. Curr Urol Rep. Jul 2005;6(4):307-12. [Medline].

68. Skerk V, Sternak SL, Roglic S, et al. Diagnosis and treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother. Oct 2005;17(5):570-1. [Medline].

69. Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med. Sep 16 1991;91(3B):65S-71S. [Medline].

70. Stamm WE. Measurement of pyuria and its relation to bacteriuria. Am J Med. Jul 28 1983;75(1B):53-8. [Medline].

71. Stamm WE, Hooton TM. Management of Urinary Tract Infections in Adults. N Engl J Med. 1993;329:1328-33. [Medline].

72. Viswaroop BS, Kekre N, Gopalakrishnan G. Isolated tuberculous epididymitis: a review of forty cases. J Postgrad Med. Apr-Jun 2005;51(2):109-11, discussion 111. [Medline].

73. Wagenlehner FM, Naber KG. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin Microbiol Infect. May 2006;12 Suppl 3:67-80. [Medline].

74. Wagenlehner FM, Naber KG. Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men. Curr Urol Rep. Aug 2004;5(4):309-16. [Medline].

75. Wagenlehner FM, Naber KG. Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men. Curr Infect Dis Rep. Jan 2005;7(1):9-16. [Medline].

76. Wagenlehner FM, Naber KG, Weidner W. Chlamydial infections and prostatitis in men. BJU Int. Apr 2006;97(4):687-90. [Medline].

77. Wagenlehner FM, Weidner W, Naber KG. Therapy for prostatitis, with emphasis on bacterial prostatitis. Expert Opin Pharmacother. Aug 2007;8(11):1667-74. [Medline].

78. Warren JW, Tenney JH, Hoopes JM, et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. Dec 1982;146(6):719-23. [Medline].

79. Yap RL, Jang TL, Gupta R, et al. Xanthogranulomatous orchitis. Urology. Jan 2004;63(1):176-7. [Medline].

Further Reading

Keywords

male urinary tract infection, urinary infection, UTI, prostatitis, epididymitis, orchitis, pyelonephritis, cystitis, indwelling urethral catheters, catheter, gonorrhea, obstruction, prostatic hypertrophy, urinary tract instrumentation, catheterization, urological surgery

Contributor Information and Disclosures

Author

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Medical Editor

Klaus-Dieter Lessnau, MD, FCCP, Clinical Associate Professor of Medicine, New York University School of Medicine; Medical Director, Pulmonary Physiology Laboratory; Director of Research in Pulmonary Medicine, Department of Medicine, Section of Pulmonary Medicine, Lenox Hill Hospital
Klaus-Dieter Lessnau, MD, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Medical Association, American Society for Artificial Internal Organs, American Thoracic Society, Physicians for Social Responsibility, and Society of Critical Care Medicine
Disclosure: sepracor Ownership interest None

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Mark Jeffrey Noble, MD, Consulting Staff, Urologic Institute, Cleveland Clinic Foundation
Mark Jeffrey Noble, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Kansas Medical Society, Sigma Xi, Society of University Urologists, and Southwest Oncology Group
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Michael Stuart Bronze, MD, Professor, Stewart G Wolf Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center
Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physician Executives, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Association of Professors of Medicine, Association of Program Directors in Internal Medicine, Infectious Diseases Society of America, Oklahoma State Medical Association, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.